Navigation Links
Boston Scientific Begins Clinical Trial for Next-Generation Nitinol Stent to Treat Iliac Artery Disease
Date:5/20/2009

25 sites in the U.S. and will examine rates of device- and/or procedure-related major adverse events (MAE) at nine months. MAE are currently defined as death within 30 days, myocardial infarction (MI, or heart attack) occurring during related hospitalization, target vessel revascularization (TVR) through nine months and amputation of the treated limb through nine months.

The EPIC Stent is a next-generation product that builds on Boston Scientific's long-time leadership in the peripheral interventions market. The Company's peripheral product lines feature technologies used to diagnose and treat peripheral disease, including stents, balloon catheters, sheaths, wires, peripheral embolization solutions and vena cava filters. This advanced product portfolio offers physicians a range of peripheral stent indications, including the Carotid Wallstent(R) Endoprosthesis for carotid artery disease and the Express(R) SD Stent for renal artery disease.

The EPIC Nitinol Stent System is an investigational device and is limited by applicable law to investigational use only and is not available for sale in the U.S.

Boston Scientific is a worldwide developer, manufacturer and marketer of medical devices whose products are used in a broad range of interventional medical specialties. For more information, please visit: www.bostonscientific.com.

Cautionary Statement Regarding Forward-Looking Statements

This press release contains forward-looking statements within the meaning of Section 21E of the Securities Exchange Act of 1934. Forward-looking statements may be identified by words like "anticipate," "expect," "project," "believe," "plan," "estimate," "intend" and similar words. These forward-looking statements are based on our beliefs, assumptions and estimates using information available to us at the time and are
'/>"/>

SOURCE Boston Scientific Corporation
Copyright©2009 PR Newswire.
All rights reserved

Page: 1 2 3 4

Related medicine technology :

1. Boston Scientific Launches Third-Generation Platinum Chromium Drug-Eluting Stent
2. Boston Scientific Data Show Real-World Survival Rates for Implantable Cardiac Device Patients Exceed Rates From Clinical Trials
3. Journal of American College of Cardiology Article Reports Fewer Repeat Procedures With Boston Scientifics TAXUS(R) Liberte(R) Stent
4. Boston Scientific Welcomes Publication of HORIZONS AMI Trial Results in New England Journal of Medicine
5. Clinical Data Reinforce Safety and Efficacy of Boston Scientifics Two Drug- Eluting Stent Platforms
6. New England Journal of Medicine Publishes Results from Boston Scientifics Landmark SYNTAX(TM) Trial
7. Boston Scientific Submits Final Modules to FDA for Approval of Second-Generation Small Vessel and Long Lesion Stents
8. Boston Scientific Begins Clinical Trial Enrollment for New Everolimus-Eluting Stent
9. Taxus Atlas Studies Reinforce Safety and Efficacy of Boston Scientifics Next-Generation Taxus Liberte Stent
10. Boston Scientific to Release Broad Range of Clinical Trial Data on the Performance of TAXUS(R) Coronary Stent Systems at TCT 2008
11. Boston Scientific Completes Clinical Trial Enrollment for Third-Generation Drug-Eluting Stent
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:11/22/2014)... , Nov. 21, 2014  Particle Sciences, Inc ... has developed and manufactured a new innovative vaginal ... Research and Development arm of Exeltis Pharmaceuticals.  According ... Project Management at Particle Sciences, "This vaginal ring ... our material sciences and modeling expertise.  We are ...
(Date:11/21/2014)... Md. , Nov. 21, 2014  The University ... will host the ceremonial groundbreaking of the new A. ... Park. The new building will cultivate transformative new engineering ... Taking place at 10:00 a.m. on November ... the Paint Branch Parking Lot, adjacent to the Jeong ...
(Date:11/21/2014)... Fla. , Nov. 21, 2014   Rock ... announced that the Company is scheduled to present at ... San Francisco, CA on January 12-14, 2015. ... Chairman and CEO of Rock Creek Pharmaceuticals, will present ... molecule cholinergic agonist which exhibits anti-inflammatory pharmacological characteristics. Dr. ...
Breaking Medicine Technology:Particle Sciences' Clinical Trial Supplies Group Manufactures Innovative Vaginal Ring 2University of Maryland Breaks Ground for A. James Clark Hall 2University of Maryland Breaks Ground for A. James Clark Hall 3University of Maryland Breaks Ground for A. James Clark Hall 4Rock Creek Pharmaceuticals to Present at the Biotech Showcase 2015 2Rock Creek Pharmaceuticals to Present at the Biotech Showcase 2015 3Rock Creek Pharmaceuticals to Present at the Biotech Showcase 2015 4
... DIEGO, June 10, 2011 Gen-Probe Incorporated (NASDAQ: ... the William Blair & Company 31st Annual Growth Stock Conference ... Central Time (5 p.m. Eastern Time).  The presentation is scheduled ... link on the investors section of Gen-Probe,s website at ...
... HANOVER, N.J., June 10, 2011 Unity Management ... is a Health Resource Company specializing in Physician ... and Technologies, along with Pharmacy Instrumentation, Calibration, Data ... is pleased to announce today that (MCC) Metropolitan ...
Cached Medicine Technology:Gen-Probe to Webcast Presentation at the William Blair & Company 31st Annual Growth Stock Conference 2Unity Management Group, MCC Announce Increased Contracts and Major Installations at US and South American Pharmaceutical Companies 2Unity Management Group, MCC Announce Increased Contracts and Major Installations at US and South American Pharmaceutical Companies 3
(Date:11/24/2014)... 24, 2014 SWAccessControl.com has recently ... a matter of fact, the company is a leading online ... new magnetic locks are available at discounted prices, up to ... range of magnetic locks. This time, all of our items ... at home and abroad, so I have confidence in our ...
(Date:11/24/2014)... and Philadelphia, PA (PRWEB) November 24, 2014 ... of care coordination and disease management services to ... chosen to implement Essette’s Medical Management software suite. ... Essette SaaS platform in a program to reduce ... suite includes Population Health Management, Care Management, Utilization ...
(Date:11/23/2014)... Dallas, TX (PRWEB) November 24, 2014 ... Trials Review, H2, 2014" provides data on the ... information and data relating to the clinical trials ... trial numbers and their recruitment status as per ... The databook offers a preliminary coverage of disease ...
(Date:11/23/2014)... November 24, 2014 Tbdress.com has ... available online on Nov. 28, 2014. The special offer will ... , Tbdress.com is one of the world’s largest women’s dresses ... and colors. People can enjoy great discounts on that day: ... enjoy free delivery (for orders above $89). , People can ...
(Date:11/23/2014)... (HealthDay News) -- The holidays can be a challenge ... can trigger major meltdowns, an expert says. "Holidays ... circumstances, but when you have children with special needs, ... therapy professor at University of the Sciences in Philadelphia, ... to let your hosts or visitors know what special ...
Breaking Medicine News(10 mins):Health News:SWAccessControl.com Is Happy To Release New Range Of Magnetic Locks 2Health News:ReAdmission Solutions, LLC Selects Essette 2Health News:Aspergillosis Pipeline and Clinical Trials Market (Compnies and Drugs) Review H2 2014 Report at ReportsnReports.com 2Health News:Aspergillosis Pipeline and Clinical Trials Market (Compnies and Drugs) Review H2 2014 Report at ReportsnReports.com 3Health News:Aspergillosis Pipeline and Clinical Trials Market (Compnies and Drugs) Review H2 2014 Report at ReportsnReports.com 4Health News:Tbdress.com Special Friday Shoes Sales Online Now 2Health News:Holidays Can Be Sensory Overload for Kids With Autism 2
... that have only about 20 nucleotides and do not code ... binding to target messenger RNAs the instructions for protein ... cancer, the production of some miRNAs is often reduced or ... cancer-promoting genes. A key molecule in the development ...
... Thomas J. Watkins Professor of Obstetrics and Gynecology at ... Presidential Award for Excellence in Science, Mathematics and Engineering ... Monday, Dec. 12. The award was for ... Program for High School Girls and Beyond. The program ...
... 16 (HealthDay News) -- Men often have difficulty accurately reading a ... In what should come as no surprise to any woman who,s ... tends to think all women want him, while other guys just ... included 96 male and 103 female U.S. college undergraduates who took ...
... Europe provide plentiful food in summer, finding enough to eat ... avoid the problem by hibernating but this survival strategy is ... of some bears, large mammals remain fully awake throughout the ... with the comparative scarcity of food. Red deer, for ...
... for cystic fibrosis produced sustained improvement in lung function ... study. Along with the treatment,s efficacy and good safety ... treatment may improve adherence with therapy in these patients. ... Pharmaxis Limited, 318 patients were randomized to treatment with ...
... antiretroviral therapy (ART) appears preferable to deferring treatment, according ... of Infectious Diseases and now available online. Although ... unproven, the findings support growing evidence favoring earlier ART ... of Wisconsin in Milwaukee, led a team of researchers ...
Cached Medicine News:Health News:No brakes on breast cancer cells 2Health News:Northwestern scientist gets mentoring award at White House 2Health News:Northwestern scientist gets mentoring award at White House 3Health News:Men Often Misread Women's Sexual Cues: Study 2Health News:Winter diets? The secret is to chill the extremities 2Health News:Winter diets? The secret is to chill the extremities 3Health News:Long-term inhaled dry powder mannitol improves lung function in CF 2Health News:Study suggests early ART in recently HIV-infected patients preferable to delayed treatment 2
Freer elevator, double end, 7 1/4", S/B....
... Surgifoam* absorbable gelatin sponge, U.S.P. is ... absorbable sponge intended for hemostatic use ... The sponge is off-white and porous ... to hemostasis, highly favorable surgeon preference ...
8 mm diameter curved probes with suture eyes just back of blunt ends. Stainless steel. Round knurled handle with polished finish. Overall length: 5.6 inches....
Yag Laser System SYL is compact and light-weight. It is CE Mark approved according to MDD....
Medicine Products: